Functional respiratory evaluation in the coronavirus disease-19 era: The role of pulmonary function test laboratories.
Gespeichert in:
| Titel: | Functional respiratory evaluation in the coronavirus disease-19 era: The role of pulmonary function test laboratories. |
|---|---|
| Autoren: | Gochicoa-Rangel L; Department of Respiratory Physiology, Instituto Nacional de Enfermedades Respiratorias 'Ismael Cosío Villegas', Mexico City, Mexico., Torre-Bouscoulet L; Laboratory of Pulmonary Function Tests, Instituto de Desarrollo e Innovación en Fisiología Respiratoria, Mexico City, Mexico. Electronic address: luis.torre@infire.mx., Salles Rojas A; Department of Respiratory Physiology, Instituto Nacional de Enfermedades Respiratorias 'Ismael Cosío Villegas', Mexico City, Mexico., Guzmán-Valderrábano C; Department of Respiratory Physiology, Instituto Nacional de Enfermedades Respiratorias 'Ismael Cosío Villegas', Mexico City, Mexico., Esperanza Benítez-Pérez R; Department of Continuous Education, Instituto Nacional de Enfermedades Respiratorias 'Ismael Cosío Villegas', Mexico City, Mexico., Salas Escamilla I; Department of Respiratory Physiology, Instituto Nacional de Enfermedades Respiratorias 'Ismael Cosío Villegas', Mexico City, Mexico., Monráz-Pérez S; Coordination of Medical Care, Instituto Nacional de Enfermedades Respiratorias 'Ismael Cosío Villegas', Mexico City, Mexico., Manuel Grosso-Espinosa J; Laboratory of Pulmonary Function Tests, Instituto de Desarrollo e Innovación en Fisiología Respiratoria, Mexico City, Mexico. |
| Körperschaften: | Latin-American Society of Respiratory Physiology (SOLAFIRE) |
| Quelle: | Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion [Rev Invest Clin] 2025 Jul-Aug; Vol. 77 (4), pp. 100011. Date of Electronic Publication: 2025 Sep 17. |
| Publikationsart: | Journal Article; Review |
| Sprache: | English |
| Info zur Zeitschrift: | Publisher: Permanyer Country of Publication: Mexico NLM ID: 9421552 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 0034-8376 (Print) Linking ISSN: 00348376 NLM ISO Abbreviation: Rev Invest Clin Subsets: MEDLINE |
| Imprint Name(s): | Publication: Barcelona : Permanyer Original Publication: Mexico City : Instituto Nacional de la nutrición |
| MeSH-Schlagworte: | COVID-19*/physiopathology , Respiratory Function Tests*/standards , Respiratory Function Tests*/methods , Laboratories*/standards, Humans ; Adult ; Quality Control ; Child |
| Abstract: | The pandemic character of coronavirus disease-19 (COVID-19) requires strategy changes designed to guarantee the safety of patients and health-care professionals. We are greatly concerned by the limitations in the operation of pulmonary function test (PFT) laboratories, since there is a high risk of disease progression in patients with chronic pulmonary diseases, and we are now faced by the influx of a new group of individuals in the recovery phase of post-COVID-19-syndrome that requires evaluation and follow-up of their respiratory function. To reestablish the operation of PFT laboratories limiting the risk of cross-contamination, we herein present the consensus reached by a group of experts in respiratory physiology, most of whom work in PFT laboratories in several Latin-American countries, on the applicable recommendations for severe acute respiratory syndrome coronavirus 2 pneumonia survivors when undergoing PFT. We present the safety and hygiene measures that must be adopted in laboratories or centers where PFT is conducted in adults and/or children. These recommendations answer the following questions: which PFT is most recommended in subjects that have recovered from COVID-19; what quality control and safety measures should PFT laboratories implement during this pandemic? And how should we approach non-COVID-19 patients requiring PFT? (Copyright © 2025 The Author(s). Published by Elsevier España S.L.U. All rights reserved.) |
| Contributed Indexing: | Keywords: Coronavirus disease-19; Pulmonary function test laboratories; Pulmonary function tests; Quality and safety measures; Severe acute respiratory syndrome coronavirus 2 |
| Entry Date(s): | Date Created: 20250918 Date Completed: 20251001 Latest Revision: 20251001 |
| Update Code: | 20251002 |
| DOI: | 10.24875/RIC.20000250 |
| PMID: | 40966832 |
| Datenbank: | MEDLINE |
Full Text Finder 
Nájsť tento článok vo Web of Science | Abstract: | The pandemic character of coronavirus disease-19 (COVID-19) requires strategy changes designed to guarantee the safety of patients and health-care professionals. We are greatly concerned by the limitations in the operation of pulmonary function test (PFT) laboratories, since there is a high risk of disease progression in patients with chronic pulmonary diseases, and we are now faced by the influx of a new group of individuals in the recovery phase of post-COVID-19-syndrome that requires evaluation and follow-up of their respiratory function. To reestablish the operation of PFT laboratories limiting the risk of cross-contamination, we herein present the consensus reached by a group of experts in respiratory physiology, most of whom work in PFT laboratories in several Latin-American countries, on the applicable recommendations for severe acute respiratory syndrome coronavirus 2 pneumonia survivors when undergoing PFT. We present the safety and hygiene measures that must be adopted in laboratories or centers where PFT is conducted in adults and/or children. These recommendations answer the following questions: which PFT is most recommended in subjects that have recovered from COVID-19; what quality control and safety measures should PFT laboratories implement during this pandemic? And how should we approach non-COVID-19 patients requiring PFT?<br /> (Copyright © 2025 The Author(s). Published by Elsevier España S.L.U. All rights reserved.) |
|---|---|
| ISSN: | 0034-8376 |
| DOI: | 10.24875/RIC.20000250 |